Interaction between the UCP2 -866 G>A polymorphism, diabetes, and β-blocker use among patients with acute coronary syndromesAmber L. Beitelshees, Daniel P. Kelly, Samuel Klein et al.|Pharmacogenetics and Genomics|2010Cited by 17